Polygenic Risk Scores: Clinical Utility and Challenges
Genome Medicine
Summary
This study reviews the transition of Polygenic Risk Scores (PRS) from research settings to potential clinical applications, evaluating their predictive power and limitations.
Study Design
Interventions
Study Type
Outcomes
Duration and Size
Study Population
Geography
Methodology
The study uses a meta-analysis approach to review existing research on PRS across different diseases. It highlights how PRS is constructed using genome-wide association study data and discusses statistical methodologies such as LDpred and PRSice. Key considerations include PRS validation, population stratification, and clinical applicability.
Interventions
The study discusses PRS as a genetic tool for identifying individuals at increased disease risk. It reviews how PRS is used in cardiovascular disease, diabetes, and psychiatric disorders for risk stratification and potential early interventions.
Key Findings
Polygenic risk scores show promise in predicting individual disease risk, especially for cardiovascular conditions, type 2 diabetes, and psychiatric disorders. However, PRS faces challenges such as limited predictive accuracy, lack of validation in diverse populations, and ethical concerns regarding genetic determinism. The study emphasizes the need for further research before PRS can be fully integrated into clinical practice.
Comparison with other Studies
Polygenic risk scores (PRS) have emerged as promising tools for predicting genetic susceptibility to various diseases, yet their clinical utility remains debated. Lewis and Vassos (2020) discuss PRS as potential instruments for risk stratification, but emphasize their limited predictive power in isolation. Similarly, a Nature Communications (2019) study found PRS accuracy varies significantly across ancestral populations, highlighting the need for more diverse genetic datasets. A 2023 BMJ Medicine review concluded that while PRS modestly improve risk prediction when combined with clinical factors, they are insufficient as standalone diagnostic tools. Conversely, a Circulation: Genomic and Precision Medicine (2021) review found PRS useful for coronary artery disease and hypertension, especially when integrated with traditional assessments. These studies collectively suggest that while PRS offer valuable insights into genetic predisposition, their reliability and applicability depend on improving their predictive accuracy, ensuring diverse population representation, and integrating them effectively into existing clinical frameworks.
Journal Reference
Lewis CM, Vassos E. Polygenic risk scores: from research tools to clinical instruments. Genome Med. 2020;12(1):44. doi:10.1186/s13073-020-00742-5
Related and Discussions
Key References
Most relevant evidence and guidance related to this research.
Supporting Evidence
Supporting evidence and related resources.
Polygenic Risk Scores: Clinical Utility and Challenges
Challenging the Assumptions of Polygenic Risk Scores
A New Era of Designer Babies May Be Based on Overhyped Science
Unmasking Alzheimer's Disease Risk in Young Adults
A Field at a Crossroads: Genetics and Racial Mythmaking
How Can Trump's Announced $500 Billion Investment In AI Change Healthcare?
30 total sources in this category